Genentech shares will be in focus
Monday, October 15, 2007
Genentech shares will be in focus tomorrow after company reported after market close a surge in third-quarter earnings that barely beat Wall Street projections, while its revenue increase fell just short of estimates. Looking at the daily chart stock is actually trading in a short downtrend but above its 50 dma. Indications are printing mixed signs with RSI in the neutral zone and MACD in territory Bearish below 0. So, keep an eye on DNA after today earnings. Resistance is at $78.19 and support at $76.26.
Disclaimer : Trading stocks involves risk, this information should not be viewed as trading recommendations. The charts provided here are not meant for investment purposes and only serve as technical examples
Labels: DNA
